2019年冠状病毒病(COVID-19)
地塞米松
病危
医学
冠状病毒
2019-20冠状病毒爆发
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
病毒学
重症监护医学
药品
类固醇
药理学
内科学
爆发
疾病
传染病(医学专业)
激素
出处
期刊:Nature
[Nature Portfolio]
日期:2020-06-16
卷期号:582 (7813): 469-469
被引量:353
标识
DOI:10.1038/d41586-020-01824-5
摘要
In a large trial, a cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19. In a large trial, a cheap and widely available steroid cut deaths by one-third among patients critically ill with COVID-19.
科研通智能强力驱动
Strongly Powered by AbleSci AI